Related Experiment Video

Updated: Jan 25, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.5K

Receptor radionuclide targeting for neuroendocrine tumors (NET) diagnostic and therapy

Lavinia Vija1, Lawrence Dierickx1, Frederic Courbon2

  • 1Service de médecine nucléaire, institut universitaire du cancer Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.

Annales D'Endocrinologie
|May 5, 2019
PubMed

Insights

Peptide radionuclide radiation therapy (PRRT) using 177Lutetium improves progression-free survival for advanced neuroendocrine tumors (NETs). This theragnostic approach targets somatostatin receptors (SSTR) and is optimal for select NET patients.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Endocrinology

Background:

  • Neuroendocrine tumors (NETs) express somatostatin receptors (SSTR), enabling theragnostic applications.
  • Peptide radionuclide radiation therapy (PRRT) utilizes this SSTR expression for targeted treatment.
  • The NETTER-1 trial demonstrated efficacy of 177Lutetium-based PRRT in advanced intestinal NETs.

Purpose of the Study:

  • To provide an overview of SSTR-targeting radionuclides in diagnostic imaging and PRRT for NETs.
  • To discuss the mechanism and clinical application of PRRT in endocrine tumors.
  • To explore the role of PRRT within the personalized medicine paradigm for NETs.

Main Methods:

  • Review of literature on receptor radionuclide utilization in diagnostic imaging.
  • Focus on the mechanism and application of PRRT for endocrine tumors.
  • Analysis of clinical data, including the NETTER-1 phase III trial.

Main Results:

  • 177Lutetium-based PRRT significantly improved progression-free survival in advanced intestinal NETs (NETTER-1 trial).
  • PRRT is indicated for G1-G2 well-differentiated NETs with high SSTR expression.
  • Optimal candidates for PRRT likely have low tumor burden and slow disease progression.

Conclusions:

  • PRRT represents a key theragnostic strategy in personalized medicine for NET patients.
  • The precise positioning of PRRT within the treatment algorithm requires further exploration.
  • Continued research is needed to optimize patient selection and treatment protocols for PRRT in NETs.
Keywords:
Ga-DOTA-PET/CTL’imagerie des tumeurs neuroendocrinesNeuroendocrine tumor imagingPRRTTEP/TDM Ga-DOTATheranosticsThéranostique

More Related Videos

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.5K
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids09:43

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Published on: October 14, 2019

6.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
663
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.4K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.7K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.4K